DAVID V SMITH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID V SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID V SMITH. DAVID V SMITH is V.P. & Chief Financial Officer in CHIRON CORP ($CHIR) and V.P.; Chief Financial Officer in CHIRON CORP ($CHIR) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Executive Vice President & CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CODEXIS INC ($CDXS).
Latest Insider Trading Transactions of DAVID V SMITH
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, CHIR, CDXS, FPRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 12.47 | 185,000 | 2,306,950 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Sell | D | 38.00 | 138,947 | 5,279,986 | 0 | 138.9 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 66,000 | 0 | 138,947 | 72.9 K to 138.9 K (+90.48 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 25.71 | 5,110 | 131,378 | 72,947 | 78.1 K to 72.9 K (-6.55 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 16.14 | 11,504 | 185,675 | 78,057 | 89.6 K to 78.1 K (-12.84 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Buy | M | 0.00 | 22,000 | 0 | 89,561 | 67.6 K to 89.6 K (+32.56 %) |
Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
Jun 18 2020 | CDXS | CODEXIS, INC. | Smith David V | Director | Grant | A | 0.00 | 8,952 | 0 | 8,952 | 0 to 9 K |
Jun 18 2020 | CDXS | CODEXIS, INC. | Smith David V | Director | Gift | G | 0.00 | 4,947 | 0 | 0 | 4.9 K to 0 (-100.00 %) |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 63,389 | 48.4 K to 63.4 K (+31.00 %) |
Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 48,389 | 33.4 K to 48.4 K (+44.92 %) |
Nov 27 2019 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 3.77 | 6,611 | 24,923 | 33,389 | 40 K to 33.4 K (-16.53 %) |
Jun 26 2019 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 0.00 | 44,000 | 0 | 44,000 | |
Jun 13 2019 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 4,947 | 0 | 4,947 | 0 to 4.9 K |
Nov 27 2018 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 12.47 | 185,000 | 2,306,950 | 185,000 | |
Nov 27 2018 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Jun 12 2018 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 5,923 | 0 | 5,923 | 0 to 5.9 K |
Jun 12 2018 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 5,923 | 0 | 5,923 | 0 to 5.9 K |
Apr 05 2018 | CDXS | CODEXIS INC | Smith David V | Director | Sell | S | 10.37 | 6,000 | 62,213 | 56,679 | 62.7 K to 56.7 K (-9.57 %) |
Jun 16 2017 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 17,894 | 0 | 62,679 | 44.8 K to 62.7 K (+39.96 %) |
Jun 17 2016 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 20,094 | 0 | 44,785 | 24.7 K to 44.8 K (+81.38 %) |
May 27 2016 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 1.00 | 22,500 | 22,500 | 22,500 | |
May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Buy | M | 0.00 | 2,500 | 0 | 9,500 | 7 K to 9.5 K (+35.71 %) |
Mar 03 2016 | CDXS | CODEXIS INC | Smith David V | Director | Grant | A | 0.00 | 24,691 | 0 | 24,691 | 0 to 24.7 K |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Buy | M | 0.00 | 2,500 | 0 | 7,000 | 4.5 K to 7 K (+55.56 %) |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 0.00 | 1,900 | 0 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 0.00 | 12,000 | 0 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 33.88 | 67,500 | 2,286,900 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 36.34 | 14,000 | 508,690 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 42.54 | 12,000 | 510,420 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 45.72 | 14,000 | 640,063 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | D | 22.00 | 15,625 | 343,750 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Sell | D | 48.00 | 2,179 | 104,592 | 0 | 2.2 K to 0 (-100.00 %) |
Feb 22 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
Feb 22 2006 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Payment of Exercise | F | 45.20 | 319 | 14,419 | 4,079 | 4.4 K to 4.1 K (-7.25 %) |
Feb 23 2005 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Option Exercise | A | 33.88 | 67,500 | 2,286,900 | 67,500 | |
Feb 23 2005 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Payment of Exercise | F | 34.46 | 220 | 7,580 | 4,304 | 4.5 K to 4.3 K (-4.86 %) |
Feb 18 2005 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Payment of Exercise | F | 35.35 | 359 | 12,691 | 4,524 | 4.9 K to 4.5 K (-7.35 %) |
Feb 25 2004 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Payment of Exercise | F | 49.43 | 463 | 22,886 | 4,883 | 5.3 K to 4.9 K (-8.66 %) |
Feb 24 2004 | CHIR | CHIRON CORP | SMITH DAVID V | V.P. & Chief Financ ... | Payment of Exercise | F | 49.96 | 214 | 10,690 | 5,346 | 5.6 K to 5.3 K (-3.85 %) |
Feb 17 2004 | CHIR | CHIRON CORP | SMITH DAVID V | V.P.; Chief Financi ... | Option Exercise | A | 51.98 | 60,000 | 3,118,800 | 60,000 |
Page: 1